Content - Volume 53, Issue

All articles

Double-blind trial of miconazole in dermatomycosis
Else Svejgaard
A double-blind study of miconazole (Brentan®) has been performed in 86 patients suffering from dermatomycosis. Of the 65 patients not lost to follow-up, 30 had received the active drug, and 35 placebo. The cure-rate was significantly (p=0.03) higher in patients receiving miconazole (70%) than in those on placebo (40%). The higher cure-rate was found in patients suffering from cutaneous candidiasi ...
Pages: 497-499
Abstract  PDF